Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar

Thread starter International: Top News And Analysis
Start date Oct 30, 2025

International: Top News And Analysis

Guest

Oct 30, 2025

The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a class of obesity and diabetes drugs called GLP-1s.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar

Prefix: N/A

Forum: World News

Start date: Oct 30, 2025

Last reply date: Oct 30, 2025

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Oct 30, 2025

Replies: 0

Views: 9

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search